| Literature DB >> 30719405 |
Nancy L Schoenborn1, Qian-Li Xue1,2, Craig E Pollack2, Ellen M Janssen3, John F P Bridges4, Antonio C Wolff1, Cynthia M Boyd1.
Abstract
Many older adults receive routine cancer screening even when it is no longer recommended. We sought to identify demographic, health-related, and attitudinal factors that are most predictive of continued breast, colorectal, and prostate cancer screening decisions in older adults under various scenarios. A sample of adults age 65+ (n = 1272) were recruited from a nationally representative panel in November 2016, of which 881 (69.3%) completed our survey. Participants were presented vignettes in which we experimentally varied a hypothetical patient's life expectancy, age, quality of life, and physician screening recommendation. The dependent variable was the choice to continue cancer screening in the vignette. Classification and regression tree (CART) analysis was used to identify characteristics most predictive of screening decisions; both the participants' characteristics and the hypothetical patient's characteristics in the vignettes were included in the analysis. CART analysis uses recursive partitioning to create a classification tree in which variables predictive of the outcome are included as hierarchical tree nodes. We used automated ten-fold cross-validation to select the tree with lowest misclassification and highest predictive accuracy. Participants' attitude towards cancer screening was most predictive of choosing screening. Among those who agreed with the statement "I plan to get screened for cancer for as long as I live" (n = 300, 31.9%), 73.2% chose screening and 57.2% would still choose screening if hypothetical patient had 1-year life expectancy. For this subset of older adults with enthusiasm towards screening even when presented with scenario involving limited life expectancy, efforts are needed to improve informed decision-making about screening.Entities:
Keywords: CART analysis; Cancer screening; Decision-making; Life expectancy
Year: 2019 PMID: 30719405 PMCID: PMC6350222 DOI: 10.1016/j.pmedr.2019.01.007
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Characteristics of participants in a national online survey conducted in November 2016.a, b
| Characteristics | Aggregate (n = 881) | Screening attitude: I plan to get screened for breast/prostate/colorectal cancer for as long as I live | p-Value | ||
|---|---|---|---|---|---|
| Strongly agree/agree (n = 300) | Neither agree nor disagree (n = 260) | Strongly disagree/disagree (n = 266) | |||
| Age, year - mean (SD) | 73.4 (6.1) | 72.2 (5.3) | 72.0 (5.5) | 75.7 (6.9) | <0.001 |
| Female sex | 464 (55.2%) | 165 (60.6%) | 128 (50.3%) | 147 (55.3%) | 0.16 |
| Race | 0.002 | ||||
| White, non-Hispanic | 576 (77.2%) | 180 (75.0%) | 162 (70.2%) | 201 (84.7%) | |
| Black, non-Hispanic | 216 (8.8%) | 91 (11.6%) | 63 (7.6%) | 44 (6.5%) | |
| Hispanic | 47 (8.2%) | 20 (11.0%) | 17 (10.3%) | 8 (4.2%) | |
| Other | 42 (5.8%) | 9 (2.5%) | 18 (11.9%) | 13 (4.7%) | |
| Cancer screening type in the survey | 0.003 | ||||
| Prostate | 208 (22.5%) | 58 (15.8%) | 66 (26.6%) | 58 (21.6%) | |
| Colorectal | 441 (49.8%) | 146 (47.5%) | 139 (51.2%) | 148 (57.6%) | |
| Breast | 232 (27.7%) | 96 (36.6%) | 55 (22.2%) | 60 (20.8%) | |
| Has ever had a mammogram/prostate-specific antigen (PSA) test/colonoscopy | 744 (81.2%) | 275 (92.1%) | 218 (75.7%) | 196 (72.4%) | <0.001 |
| Has had an up-to-date mammogram/PSA test/colonoscopy | 631 (66.0%) | 260 (85.2%) | 174 (55.4%) | 148 (53.7%) | <0.001 |
| Physician have recommended stopping mammogram/PSA test/colonoscopy | 76 (9.7%) | 6 (2.0%) | 19 (6.8%) | 46 (20.1%) | <0.001 |
| <10 year predicted life expectancy | 197 (31.1%) | 51 (22.7%) | 47 (26.9%) | 70 (36.5%) | 0.03 |
| <10 year self-perceived life expectancy | 110 (16.6%) | 25 (11.7%) | 27 (14.1%) | 54 (24.9%) | 0.008 |
| Education | 0.23 | ||||
| <High school | 61 (14.4%) | 22 (16.4%) | 20 (17.8%) | 17 (9.9%) | |
| High school | 271 (33.3%) | 81 (29.7%) | 91 (34.3%) | 82 (35.3%) | |
| <4 year college | 243 (24.1%) | 93 (26.6%) | 69 (24.8%) | 69 (21.8%) | |
| College or higher | 306 (28.2%) | 104 (27.4%) | 80 (23.2%) | 98 (33.0%) | |
| Health literacy ( | 13.1 (2.1) | 13.0 (2.3) | 12.8 (2.3) | 13.4 (1.8) | 0.002 |
| Numeracy ( | 13.8 (3.5) | 13.9 (3.6) | 13.4 (3.7) | 14.0 (3.4) | 0.56 |
| Decision making preferences | 0.18 | ||||
| Make own decisions | 533 (62.5%) | 163 (55.2%) | 163 (66.8%) | 174 (67.3%) | |
| Make decisions together | 331 (36.1%) | 130 (43.7%) | 92 (31.0%) | 88 (31.6%) | |
| Leave decision to doctor | 7 (1.4%) | 1 (1.2%) | 3 (2.2%) | 3 (1.1%) | |
Means and percentages are weighted.
Proportion of missing values were 1.0% or less for all variables except for health literacy (composite of 3 questions) which had a cumulative missing value of 1.2%, numeracy (composite of 3 questions) which had a cumulative missing value of 2.5%, and predicted life expectancy (composite of 12 variables) which had a cumulative missing value of 7.2%.
Participants with history of relevant cancer (n = 52) were excluded from this question because they would be under surveillance for recurrence of cancer, rather than screening. Three additional participants declined to answer this question.
Participants randomized to breast cancer screening questions were asked about receipt of mammogram; participants randomized to prostate cancer screening questions were asked about receipt of prostate-specific antigen test; participants randomized to colorectal cancer screening questions were asked about receipt of colonoscopy.
Up to date mammogram and PSA test were defined to be within 2 years; up to date colonoscopy was defined to be within 10 years.
Using the mortality risk index developed by Cruz et al. (2013).
Fig. 1Ten-node tree from CART analysis showing the top predictors of hypothetical breast, colorectal, and prostate cancer screening decisions among 881 older adults who completed a national online survey in November 2016.